Hepatitis C and HIV in Substance Users: Economics of Screening and Linkage to Care

Dr. Bruce R. Schackman, PhD, MBA
Saul P. Steinberg Distinguished Professor of Healthcare Policy & Research,
Director, Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV and HIV (CHERISH)


This is a free lecture and is open to the public. The lectures are geared towards researchers, clinicians, students and hospital staff.
A light lunch will be served

Eventbrite - Forefront Lectures

For more information, please contact education@cfenet.ubc.ca / local 66255


Dr. Bruce Schackman is the Saul P. Steinberg Distinguished Professor of Healthcare Policy & Research at Weill Cornell, where he conducts economic evaluations of the comparative effectiveness of health interventions alongside clinical trials and cohort studies, cost-effectiveness and comparative effectiveness simulation modeling studies, and implementation science studies-particularly relating to treatment of infectious diseases and substance use disorders. His current research includes economic evaluations of HIV and hepatitis C screening and treatment in substance use treatment settings, and economic evaluations of medication-assisted treatment of opioid use disorder.



Event Details

Days
Hours
Minutes
Seconds
Start Date
End Date
Event Category
Scroll to Top

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below